Halle John S, Halle Rob J
Belmont University, Nashville, TN, USA.
US Army-Baylor University Post-Professional Sports Medicine, Physical Therapy Doctoral Fellowship, Keller Army Community Hospital, West Point, NY, USA.
Int J Sports Phys Ther. 2016 Oct;11(5):810-819.
Dry needling (DN) is an evidence based treatment technique that is accepted and used by physical therapists in the United States. This clinical commentary is the second in a two-part series outlining some of the pertinent anatomy and other issues that are needed for optimal utilization of this treatment modality. Part one was an overview of the thorax with a summary of reported adverse effects (AEs) and the underlying anatomy that could be used to minimize patient risk. As is the case with any intervention, the technique of dry needling has some inherent patient risk. The incidence of AEs with this procedure is typically low, ranging from zero to approximately 10 percent. Knowledge of the underlying anatomy can be a key factor associated with decreasing the likelihood of an AE.
PURPOSE/OBJECTIVE: The second part of this clinical commentary goes beyond the thorax, to explore the anatomy associated with dry needling the abdomen, pelvis, and back. In the abdomen, pelvis and back, dry needling can penetrate the peritoneal cavity or adjacent organs, resulting in AEs. A physiological reaction that is an AE secondary to a needle insertion, pain or fear, is an autonomic vasovagal response. Additionally, suggestions for dealing with the fearful patient, the obese patient, universal precautions, and other clinical considerations, are discussed. The purpose of parts one and part two of this clinical commentary is to minimize the risk of a dry needling AE.
CONCLUSIONS/IMPLICATIONS: Dry needling is an effective adjunctive treatment procedure that is within the recognized scope of practice of the physical therapist. An evidence-based implementation of the procedure must be based on a thorough understanding of the underlying anatomy and the potential risks, with risks communicated to patients via informed consent.
Level 5.
干针疗法(DN)是一种基于证据的治疗技术,在美国已被物理治疗师接受并使用。本临床评论是一个两部分系列中的第二篇,概述了最佳利用这种治疗方式所需的一些相关解剖结构和其他问题。第一部分是对胸部的概述,总结了已报道的不良反应(AE)以及可用于将患者风险降至最低的相关解剖结构。与任何干预措施一样,干针疗法技术存在一些固有的患者风险。该操作的AE发生率通常较低,范围从零到约10%。了解相关解剖结构可能是降低AE发生可能性的关键因素。
本临床评论的第二部分超越胸部,探讨与腹部、骨盆和背部干针疗法相关的解剖结构。在腹部、骨盆和背部,干针疗法可能会穿透腹膜腔或邻近器官,从而导致AE。因针刺、疼痛或恐惧继发的作为AE的生理反应是自主神经血管迷走反应。此外,还讨论了应对恐惧患者、肥胖患者的建议、通用预防措施以及其他临床注意事项。本临床评论第一部分和第二部分的目的是将干针疗法AE的风险降至最低。
结论/启示:干针疗法是一种有效的辅助治疗方法,属于物理治疗师公认的执业范围内。该操作基于证据的实施必须基于对相关解剖结构和潜在风险的透彻理解,并通过知情同意将风险告知患者。
5级。